Investor Name | Invest Money | Lead Investor | Propotion | |
---|---|---|---|---|
Casdin Capital | - | Yes | - | Detail |
Redmile Group | - | Yes | - | Detail |
aMoon Fund | - | - | - | Detail |
ArrowMark Partners | - | - | - | Detail |
D1 Capital Partners | - | - | - | Detail |
Fidelity Management and Research Company | - | - | - | Detail |
Helicase Venture | - | - | - | Detail |
Irving Investors | - | - | - | Detail |
Perceptive Advisors | - | - | - | Detail |
Announced Date | Round | Money Raised | Investors | |
---|---|---|---|---|
May 30, 2018 | Series C | $ 12M | AGC,Corporation Ventures,etc. | Detail |
Feb 22, 2021 | Corporate Round | 0 | Merck Global Health Innovation Fund | Detail |
Dec 7, 2019 | Debt Financing | $ 5M | Detail | |
Jan 1, 2013 | Seed | 0 | Detail | |
Feb 2, 2016 | Series A | $ 5.10M | Oregon Venture Fund,Phoenix Venture Partners,etc. | Detail |
Jan 7, 2019 | Series D | $ 10.36M | JSR Corp,KBI Biopharma | Detail |
Aug 14, 2017 | Series B | 0 | Phoenix Venture Partners | Detail |
Jan 14, 2020 | Series D | $ 10.40M | Columbia Ventures,JSR Life Sciences,etc. | Detail |
Oct 20, 2020 | Series E | $ 69.99M | ArrowMark Partners,Casdin Capital,etc. | Detail |